Bile Duct Cancer (Cholangiocarcinoma) Treatment Market: Global Industry Analysis and Forecast 2016 - 2022


  • To Be Published : Feb-2017 |
  • Status : Work in progress |
  • Format :

Bile duct cancer (cholangiocarcinoma) is the presence of mutated epithelial cells that originate in the bile ducts. Though, cause of bile duct cancer (cholangiocarcinoma) is not certain. There are several factors that can enhance chances of developing bile duct cancer (cholangiocarcinoma). According to American Society of Clinical Oncology (ASCO), fewer than 3,000 people are affected with the disease annually in the U.S. and around 1,600 people are affected by the disease in the U.K., according to Cancer Research United Kingdom. Major indications of cholangiocarcinoma include abnormal liver function, abdominal pain, weight loss, generalized itching, discoloration of stool and urine etc. Causes of cholangiocarcinoma are not known but factors such as exposure to thorium dioxide, liver fluke infections and cholangitis have been known to increase the chances.

Bile duct cancer (cholangiocarcinoma) treatment market is driven by the technological advancement in healthcare sector and increase in prevalence of cancer patients across the globe. Also, enhanced emphasis of pharmaceutical companies on R&D to come up with potential treatment for bile duct cancer (cholangiocarcinoma). However, high cost associated with latest clinical trials and approvals act as a major barrier for global bile duct cancer (cholangiocarcinoma) treatment market.

Global bile duct cancer (cholangiocarcinoma) treatment market is classified on the basis of disease indication, by treatment type and geography.

Based on the disease indication, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:

  • Intrahepatic bile duct cancer
  • Perihilar (hilar) bile duct cancers
  • Distal bile duct cancers

Based on the treatment type, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:

  • Stent insertion
    • The PTC method
    • The ERCP method
  • Chemotherapy
    • 5-fluorouracil
    • Gemcitabine
    • Cisplatin
    • Capecitabine
    • Oxaliplatin
  • Chemoradiation

Based on the region, the global bile duct cancer (cholangiocarcinoma) treatment market is segmented into the following:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Due of the availability of variety of chemotherapeutic agents for the bile duct cancer (cholangiocarcinoma) treatment, market for chemotherapeutic agents is expected to hold a greater share in global bile duct cancer (cholangiocarcinoma) treatment market. Innovative bile duct cancer (cholangiocarcinoma) treatment procedures are expected to launch into the market in the forecast period.

Depending on geographic region bile duct cancer (cholangiocarcinoma) treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounts maximum in global bile duct cancer (cholangiocarcinoma) market share. Market for bile duct cancer (cholangiocarcinoma) treatment is maximum in North America due to advanced healthcare facilities, adequate reimbursement policies and greater awareness towards health care. Europe and Asia-Pacific market is expected to register a healthy CAGR over the forecast period.

Some of the key players in bile duct cancer (cholangiocarcinoma) are Johnson & Johnson Services, Inc., ConMed Corporation, W. L. Gore & Associates, Inc., Dispomedica GmbH, InSitu Technologies Inc., Boston Scientific Corporation, Medtronic Plc, Pauldrach medical Handels- und Vertriebs GmbH, OptiMed Medizinische Instrumente GmbH among several others.

The report covers exhaustive analysis on:

  • Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Segments
  • Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size & Forecast 2016 to 2022
  • Bile Duct Cancer (Cholangiocarcinoma) Treatment Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Bile Duct Cancer (Cholangiocarcinoma) Treatment Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance 
Back To Top